NC6 Stock Overview
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Nanollose Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.022 |
52 Week High | AU$0.074 |
52 Week Low | AU$0.02 |
Beta | 0.24 |
1 Month Change | -8.33% |
3 Month Change | 4.76% |
1 Year Change | -56.00% |
3 Year Change | -78.00% |
5 Year Change | -67.65% |
Change since IPO | -92.14% |
Recent News & Updates
Recent updates
Shareholder Returns
NC6 | AU Biotechs | AU Market | |
---|---|---|---|
7D | 0% | 2.9% | 0.4% |
1Y | -56.0% | -7.5% | 6.0% |
Return vs Industry: NC6 underperformed the Australian Biotechs industry which returned -7.5% over the past year.
Return vs Market: NC6 underperformed the Australian Market which returned 6% over the past year.
Price Volatility
NC6 volatility | |
---|---|
NC6 Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 11.3% |
Market Average Movement | 8.9% |
10% most volatile stocks in AU Market | 17.6% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: NC6 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NC6's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | n/a | www.nanollose.com |
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, non-woven fabric, and other industries.
Nanollose Limited Fundamentals Summary
NC6 fundamental statistics | |
---|---|
Market cap | AU$3.78m |
Earnings (TTM) | -AU$882.68k |
Revenue (TTM) | AU$704.58k |
5.1x
P/S Ratio-4.1x
P/E RatioIs NC6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NC6 income statement (TTM) | |
---|---|
Revenue | AU$704.58k |
Cost of Revenue | AU$391.91k |
Gross Profit | AU$312.66k |
Other Expenses | AU$1.20m |
Earnings | -AU$882.68k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0051 |
Gross Margin | 44.38% |
Net Profit Margin | -125.28% |
Debt/Equity Ratio | 223.3% |
How did NC6 perform over the long term?
See historical performance and comparison